Biotherapy Services Ltd. (BTS) is a pharmaceutical biotechnology company developing and delivering novel autologous therapies for complex and chronic wounds 🥽 🥼. Biotherapy Services, composed of clinicians, technicians, and healthcare managers, was created to bring the most effective platelet-enriching technology to medical practices in the UK and Eire 👩🔬 👨⚕️. The company has developed proprietary expertise and a unique GMP standard operational service model to provide the RAPID™ Biodynamic Haematogel autologous wound care treatment, targeting complex and chronic wounds such as Diabetic Foot Ulcers and Pressure Sores 🦵️ 🦶️. The RAPID™ Gel harnesses the patient’s own platelets to speed healing, growth, repair, and recovery 🧬️. BTS is currently conducting the RAPID-1 Trial to investigate the efficacy of RAPID™ Gel in wound closure compared to usual and customary care 🔎. Find out more about our Clinical Trial here! https://www.rapidstudy.co.uk/